Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jul. 28, 2012	Jul. 30, 2011
Cash flows from operating activities:
Net loss	$ (31,637)	$ (3,234)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Amortization of deferred financing costs	449	449
Depreciation and amortization	6,647	3,755
Provision for losses on accounts receivable	93	152
Share-based compensation expense	4,419	14
Change in operating assets and liabilities net of effect of acquisition:
Accounts receivable	9,692	369
Inventories	(13,515)	304
Prepaid expenses and other assets	2,442	719
Accounts payable	10,836	12,160
Accounts payable-affiliates	(1,405)	(4,142)
Accrued expenses and other liabilities and other long-term liabilities	(1,609)	2,598
Net cash (used in) provided by operating activities	(13,588)	13,144
Cash flows from investing activities:
Additions to property and equipment	(3,257)	(1,164)
Payment to acquire Parlux, net of Parlux cash on hand of $17,114	(44,949)	0
Net cash used in investing activities	(48,206)	(1,164)
Cash flows from financing activities:
Net borrowings (repayments) under bank line of credit	32,142	(10,825)
Payments on affiliated notes payable	0	(320)
Borrowings under affiliated notes payable to fund Parlux acquisition	30,000	0
Principal payments under capital lease obligations	(575)	(626)
Proceeds from exercise of stock options	46	4
Net cash provided by (used in) financing activities	61,613	(11,767)
Net (decrease) increase in cash and cash equivalents	(181)	213
Cash and cash equivalents at beginning of period	1,682	1,236
Cash and cash equivalents at end of period	1,501	1,449
Supplemental Information:
Cash paid during the period for Interest	868	1,031
Cash paid during the period for Income taxes	68	488
Fair value of equity consideration given to acquire Parlux	$ 89,307	$ 0